The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Dual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy
Open accessAbstract
Granulocyte macrophage colony stimulating factor (GM-CSF) is generally recognized as an inflammatory cytokine. Its inflammatory activity is primarily due its role as a growth and differentiation factor for granulocyte and macrophage populations. In this capacity, among other clinical applications, it has been used to bolster anti-tumor immune responses. GM-CSF-mediated inflammation has also been implicated in certain types of autoimmune diseases, including rheumatoid arthritis and multiple sclerosis. Thus, agents that can block GM-CSF or its receptor have been used as anti-inflammatory therapies. However, a review of literature reveals that in many situations GM-CSF can act as an anti-inflammatory/regulatory cytokine. We and others have shown that GM-CSF can modulate dendritic cell differentiation to render them "tolerogenic," which, in turn, can increase regulatory T-cell numbers and function. Therefore, the pro-inflammatory and regulatory effects of GM-CSF appear to depend on the dose and the presence of other relevant cytokines in the context of an immune response. A thorough understanding of the various immunomodulatory effects of GM-CSF will facilitate more appropriate use and thus further enhance its clinical utility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
Kantoff, P. W., Higano, C. S., Shore, N. D., Berger, E. R., Small, E. J., Penson, D. F., Redfern, C. H., Ferrari, A. C., Dreicer, R., Sims, R. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001294 · Cited by 5,572
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Chen, W., Jin, W., Hardegen, N., Lei, K.-J., Li, L., Marinos, N., McGrady, G., & Wahl, S. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030152 · Cited by 4,699
Steinman, R. M., Hawiger, D., & Nussenzweig, M. C. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141040 · Cited by 3,122
Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells
Nestle, F. O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G., & Schadendorf, D. (1998) · Nature Medicine · doi:10.1038/nm0398-328 · Cited by 2,862
Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V, Hamada, H., Pardoll, D., & Mulligan, R. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3539 · Cited by 2,818
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
Dinarello, C. A. (2011) · Blood · doi:10.1182/blood-2010-07-273417 · Cited by 2,248
Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo
Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M., Ravetch, J. V., Steinman, R. M., & Nussenzweig, M. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.769 · Cited by 1,848
Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene
Sadlack, B., Merz, H., Schorle, H., Schimpl, A., Feller, A. C., & Horak, I. (1993) · Cell · doi:10.1016/0092-8674(93)80067-o · Cited by 1,744
Colony-stimulating factors in inflammation and autoimmunity
Hamilton, J. A. (2008) · Nature reviews. Immunology · doi:10.1038/nri2356 · Cited by 1,305
Manel, N., Unutmaz, D., & Littman, D. R. (2008) · Nature Immunology · doi:10.1038/ni.1610 · Cited by 1,291
Macrophage deactivation by interleukin 10.
Bogdan, C., Vodovotz, Y., & Nathan, C. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.6.1549 · Cited by 1,238
Thurner, B., Haendle, I., Röder, C., Dieckmann, D., Keikavoussi, P., Jonuleit, H., Bender, A., Maczek, C., Schreiner, D., von den Driesch, P., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.11.1669 · Cited by 1,226
Codarri, L., Gyülvészi, G., Tosevski, V., Hesske, L., Fontana, A., Magnenat, L., Suter, T., & Becher, B. (2011) · Nature Immunology · doi:10.1038/ni.2027 · Cited by 1,191
Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products
Colotta, F., Re, F., Polentarutti, N., Sozzani, S., & Mantovani, A. (1992) · Blood · doi:10.1182/blood.v80.8.2012.2012 · Cited by 1,158
Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
Koreth, J., Matsuoka, K.-I., Kim, H. T., McDonough, S. M., Bindra, B., Alyea, E. P., Armand, P., Cutler, C., Ho, V. T., Treister, N. S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1108188 · Cited by 1,119
McGeachy, M. J., Chen, Y., Tato, C. M., Laurence, A., Joyce-Shaikh, B., Blumenschein, W. M., McClanahan, T. K., O'Shea, J. J., & Cua, D. J. (2009) · Nature Immunology · doi:10.1038/ni.1698 · Cited by 1,074
El-Behi, M., Ciric, B., Dai, H., Yan, Y., Cullimore, M., Safavi, F., Zhang, G.-X., Dittel, B. N., & Rostami, A. (2011) · Nature Immunology · doi:10.1038/ni.2031 · Cited by 1,071
Chaudhry, A., Samstein, R. M., Treuting, P., Liang, Y., Pils, M. C., Heinrich, J.-M., Jack, R. S., Wunderlich, F. T., Brüning, J. C., Müller, W., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.018 · Cited by 980
Verreck, F. A. W., de Boer, T., Langenberg, D. M. L., Hoeve, M. A., Kramer, M., Vaisberg, E., Kastelein, R., Kolk, A., de Waal-Malefyt, R., & Ottenhoff, T. H. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400983101 · Cited by 977
Volpe, E., Servant, N., Zollinger, R., Bogiatzi, S. I., Hupé, P., Barillot, E., & Soumelis, V. (2008) · Nature Immunology · doi:10.1038/ni.1613 · Cited by 938
Koch, F., Stanzl, U., Jennewein, P., Janke, K., Heufler, C., Kämpgen, E., Romani, N., & Schuler, G. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.741 · Cited by 927
IL-21 and TGF-β are required for differentiation of human TH17 cells
Yang, L., Anderson, D. E., Baecher-Allan, C., Hastings, W. D., Bettelli, E., Oukka, M., Kuchroo, V. K., & Hafler, D. A. (2008) · Nature · doi:10.1038/nature07021 · Cited by 927
Deregulated T Cell Activation and Autoimmunity in Mice Lacking Interleukin-2 Receptor β
Suzuki, H., Kündig, T. M., Furlonger, C., Wakeham, A., Timms, E., Matsuyama, T., Schmits, R., Simard, J. J. L., Ohashi, P. S., Griesser, H., et al. (1995) · Science · doi:10.1126/science.7770771 · Cited by 871
Higano, C. S., Schellhammer, P. F., Small, E. J., Burch, P. A., Nemunaitis, J., Yuh, L., Provost, N., & Frohlich, M. W. (2009) · Cancer · doi:10.1002/cncr.24429 · Cited by 810
Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells
Gallina, G., Dolcetti, L., Serafini, P., Santo, C. D., Marigo, I., Colombo, M. P., Basso, G., Brombacher, F., Borrello, I., Zanovello, P., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28828 · Cited by 792
SERAFINI, P., BORRELLO, I., & BRONTE, V (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.07.005 · Cited by 762
Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis
Saadoun, D., Rosenzwajg, M., Joly, F., Six, A., Carrat, F., Thibault, V., Sene, D., Cacoub, P., & Klatzmann, D. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105143 · Cited by 762
Li, M. O., Wan, Y. Y., & Flavell, R. A. (2007) · Immunity · doi:10.1016/j.immuni.2007.03.014 · Cited by 733
Central Role of Defective Interleukin-2 Production in the Triggering of Islet Autoimmune Destruction
Tang, Q., Adams, J. Y., Penaranda, C., Melli, K., Piaggio, E., Sgouroudis, E., Piccirillo, C. A., Salomon, B. L., & Bluestone, J. A. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.016 · Cited by 729
Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor.
Gearing, D. P., King, J. A., Gough, N. M., & Nicola, N. A. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08541.x · Cited by 681
Candido, J., & Hagemann, T. (2013) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9847-0 · Cited by 653
Meisel, C., Schefold, J. C., Pschowski, R., Baumann, T., Hetzger, K., Gregor, J., Weber-Carstens, S., Hasper, D., Keh, D., Zuckermann, H., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0363oc · Cited by 648
Maddur, M. S., Miossec, P., Kaveri, S. V., & Bayry, J. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.03.044 · Cited by 619
Purification and properties of colony-stimulating factor from mouse lung-conditioned medium.
Burgess, A. W., Camakaris, J., & Metcalf, D. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71855-3 · Cited by 613
Hayashida, K., Kitamura, T., Gorman, D. M., Arai, K., Yokota, T., & Miyajima, A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.24.9655 · Cited by 609
Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes
Naik, S. H., Metcalf, D., van Nieuwenhuijze, A., Wicks, I., Wu, L., O'Keeffe, M., & Shortman, K. (2006) · Nature Immunology · doi:10.1038/ni1340 · Cited by 605
Inaba, K., Witmer-Pack, M., Inaba, M., Hathcock, K. S., Sakuta, H., Azuma, M., Yagita, H., Okumura, K., Linsley, P. S., Ikehara, S., et al. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.5.1849 · Cited by 592
Kroenke, M. A., Carlson, T. J., Andjelkovic, A. V., & Segal, B. M. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080159 · Cited by 579
Soiffer, R., Lynch, T., Mihm, M., Jung, K., Rhuda, C., Schmollinger, J. C., Hodi, F. S., Liebster, L., Lam, P., Mentzer, S., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13141 · Cited by 571
Llorente, L., Zou, W., Levy, Y., Richaud-Patin, Y., Wijdenes, J., Alcocer-Varela, J., Morel-Fourrier, B., Brouet, J. C., Alarcon-Segovia, D., Galanaud, P., et al. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.3.839 · Cited by 541
Gilliet, M., Boonstra, A., Paturel, C., Antonenko, S., Xu, X.-L., Trinchieri, G., O'Garra, A., & Liu, Y.-J. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020045 · Cited by 524
Serafini, P., Carbley, R., Noonan, K. A., Tan, G., Bronte, V., & Borrello, I. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0757 · Cited by 523
Yu, J. S., Wheeler, C. J., Zeltzer, P. M., Ying, H., Nacis-Finger, D., Lee, P.-K., Yong, W. H., Incardona, F., Thompson, R. C., Riedinger, M. S., et al. (2001) · PubMed · Cited by 510
Tolerogenic dendritic cells: cytokine modulation comes of age
Rutella, S., Danese, S., & Leone, G. (2006) · Blood · doi:10.1182/blood-2006-03-006403 · Cited by 491
Granulocyte Macrophage Colony-Stimulating Factor
McQualter, J. L., Darwiche, R., Ewing, C., Onuki, M., Kay, T. W., Hamilton, J. A., Reid, H. H., & Bernard, C. C. A. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.7.873 · Cited by 477
Go, N. F., Castle, B. E., Barrett, R., Kastelein, R., Dang, W., Mosmann, T. R., Moore, K. W., & Howard, M. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.6.1625 · Cited by 475
Grinberg-Bleyer, Y., Baeyens, A., You, S., Elhage, R., Fourcade, G., Gregoire, S., Cagnard, N., Carpentier, W., Tang, Q., Bluestone, J., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100209 · Cited by 433
OX40 costimulation turns off Foxp3+ Tregs
Vu, M. D., Xiao, X., Gao, W., Degauque, N., Chen, M., Kroemer, A., Killeen, N., Ishii, N., & Chang Li, X. (2007) · Blood · doi:10.1182/blood-2007-01-070748 · Cited by 428
Inaba, K., Turley, S., Iyoda, T., Yamaide, F., Shimoyama, S., e Sousa, C. R., Germain, R. N., Mellman, I., & Steinman, R. M. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.6.927 · Cited by 414
Brain Dendritic Cells and Macrophages/Microglia in Central Nervous System Inflammation
Fischer, H.-G., & Reichmann, G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2717 · Cited by 411
Bronte, V., Chappell, D. B., Apolloni, E., Cabrelle, A., Wang, M., Hwu, P., & Restifo, N. P. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.10.5728 · Cited by 405
Murphy, G., Tjoa, B., Ragde, H., Kenny, G., & Boynton, A. (1996) · The Prostate · doi:10.1002/(sici)1097-0045(199612)29:6<371::aid-pros5>3.0.co;2-b · Cited by 400
GM-CSF in inflammation and autoimmunity
Hamilton, J. A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02260-3 · Cited by 373
Ponomarev, E. D., Shriver, L. P., Maresz, K., Pedras-Vasconcelos, J., Verthelyi, D., & Dittel, B. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.39 · Cited by 364
van de Laar, L., Coffer, P. J., & Woltman, A. M. (2012) · Blood · doi:10.1182/blood-2011-11-370130 · Cited by 358
Dranoff, G. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18813.x · Cited by 334
Cancer Immunotherapy Using Interleukin-2 and Interleukin-2-Activated Lymphocytes
Rosenberg, S. A., & Lotze, M. T. (1986) · Annual Review of Immunology · doi:10.1146/annurev.iy.04.040186.003341 · Cited by 314
The Structure of the GM-CSF Receptor Complex Reveals a Distinct Mode of Cytokine Receptor Activation
Hansen, G., Hercus, T. R., McClure, B. J., Stomski, F. C., Dottore, M., Powell, J., Ramshaw, H., Woodcock, J. M., Xu, Y., Guthridge, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.05.053 · Cited by 311
TGFβ signalling in control of T-cell-mediated self-reactivity
Rubtsov, Y. P., & Rudensky, A. Y. (2007) · Nature Reviews Immunology · doi:10.1038/nri2095 · Cited by 311
Hercus, T. R., Thomas, D., Guthridge, M. A., Ekert, P. G., King-Scott, J., Parker, M. W., & Lopez, A. F. (2009) · Blood · doi:10.1182/blood-2008-12-164004 · Cited by 307
Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients
Parmiani, G., Castelli, C., Pilla, L., Santinami, M., Colombo, M. P., & Rivoltini, L. (2007) · Annals of Oncology · doi:10.1093/annonc/mdl158 · Cited by 300
Salgia, R., Lynch, T., Skarin, A., Lucca, J., Lynch, C., Jung, K., Hodi, F. S., Jaklitsch, M., Mentzer, S., Swanson, S., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.091 · Cited by 296
Hierarchical down-modulation of hemopoietic growth factor receptors
Walker, F. (1985) · Cell · doi:10.1016/0092-8674(85)90032-7 · Cited by 294
Begley, C., Lopez, A., Nicola, N., Warren, D., Vadas, M., Sanderson, C., & Metcalf, D. (1986) · Blood · doi:10.1182/blood.v68.1.162.162 · Cited by 264
Seki, N., Sudo, Y., Yoshioka, T., Sugihara, S., Fujitsu, T., Sakuma, S., Ogawa, T., Hamaoka, T., Senoh, H., & Fujiwara, H. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.5.1477 · Cited by 260
HOLTL, L., RIESER, C., PAPESH, C., RAMONER, R., HEROLD, M., KLOCKER, H., RADMAYR, C., STENZL, A., BARTSCH, G., & THURNHER, M. (1999) · Journal of Urology · doi:10.1016/s0022-5347(01)61767-1 · Cited by 244
Nemunaitis, J., Sterman, D., Jablons, D., Smith, J. W., Fox, B., Maples, P., Hamilton, S., Borellini, F., Lin, A., Morali, S., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh028 · Cited by 244
The new normal: immunomodulatory agents against sepsis immune suppression
Hutchins, N. A., Unsinger, J., Hotchkiss, R. S., & Ayala, A. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.01.002 · Cited by 239
GM-CSF mediates autoimmunity by enhancing IL-6–dependent Th17 cell development and survival
Sonderegger, I., Iezzi, G., Maier, R., Schmitz, N., Kurrer, M., & Kopf, M. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071119 · Cited by 238
Campbell, I. K., Rich, M. J., Bischof, R. J., Dunn, A. R., Grail, D., & Hamilton, J. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3639 · Cited by 234
Dedhar, S., Gaboury, L., Galloway, P., & Eaves, C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.9253 · Cited by 229
The GM–CSF/IL‐3/IL‐5 cytokine receptor family: from ligand recognition to initiation of signaling
Broughton, S. E., Dhagat, U., Hercus, T. R., Nero, T. L., Grimbaldeston, M. A., Bonder, C. S., Lopez, A. F., & Parker, M. W. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01164.x · Cited by 229
Stimulation of macrophage plasminogen activator activity by colony‐stimulating factors
Hamilton, J. A., Stanley, E. R., Burgess, A. W., & Shadduck, R. K. (1980) · Journal of Cellular Physiology · doi:10.1002/jcp.1041030309 · Cited by 223
Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2+ glial cells
Kang, Z., Wang, C., Zepp, J., Wu, L., Sun, K., Zhao, J., Chandrasekharan, U., DiCorleto, P. E., Trapp, B. D., Ransohoff, R. M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3505 · Cited by 218
Current status of granulocyte–macrophage colony-stimulating factor in the immunotherapy of melanoma
Kaufman, H. L., Ruby, C. E., Hughes, T., & Slingluff, C. L. (2014) · Journal for ImmunoTherapy of Cancer · doi:10.1186/2051-1426-2-11 · Cited by 212
Nonhematopoietic tumor cells express functional GM-CSF receptors
Baldwin, G., Gasson, J., Kaufman, S., Quan, S., Williams, R., Avalos, B., Gazdar, A., Golde, D., & DiPersio, J. (1989) · Blood · doi:10.1182/blood.v73.4.1033.1033 · Cited by 209
Dieckgraefe, B. K., & Korzenik, J. R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11437-1 · Cited by 207
Functions of Granulocyte-Macrophage Colony-Stimulating Factor
Fleetwood, A. J., Cook, A. D., & Hamilton, J. A. (2005) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v25.i5.50 · Cited by 203
Two distinct functional high affinity receptors for mouse interleukin-3 (IL-3).
Hara, T., & Miyajima, A. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05239.x · Cited by 194
Kohanbash, G., McKaveney, K., Sakaki, M., Ueda, R., Mintz, A. H., Amankulor, N., Fujita, M., Ohlfest, J. R., & Okada, H. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4124 · Cited by 191
Retinoic Acid Can Directly Promote TGF-β-Mediated Foxp3+ Treg Cell Conversion of Naive T Cells
Mucida, D., Pino-Lagos, K., Kim, G., Nowak, E., Benson, M. J., Kronenberg, M., Noelle, R. J., & Cheroutre, H. (2009) · Immunity · doi:10.1016/j.immuni.2009.03.008 · Cited by 191
Cook, A. D., Braine, E. L., Campbell, I. K., Rich, M. J., & Hamilton, J. A. (2001) · Arthritis Research & Therapy · doi:10.1186/ar318 · Cited by 186
Role of IL-10 in the Resolution of Airway Inflammation
Ogawa, Y., Duru, E., & Ameredes, B. (2008) · Current Molecular Medicine · doi:10.2174/156652408785160907 · Cited by 184
Verginis, P., Li, H. S., & Carayanniotis, G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.7433 · Cited by 176
Shachar, I., & Karin, N. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0612293 · Cited by 174
Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis
Burmester, G. R., Weinblatt, M. E., McInnes, I. B., Porter, D. R., Барбараш, О. Л., Vatutin, M. T., Szombati, I., Esfandiari, E., Sleeman, M. A., Kane, C. D., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202450 · Cited by 172
Zhan, Y., Lieschke, G. J., Grail, D., Dunn, A. R., & Cheers, C. (1998) · Blood · doi:10.1182/blood.v91.3.863 · Cited by 170
GM-CSF-secreting melanoma vaccines
Dranoff, G. (2003) · Oncogene · doi:10.1038/sj.onc.1206459 · Cited by 166
G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis
Cornish, A. L., Campbell, I. K., McKenzie, B. S., Chatfield, S., & Wicks, I. P. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.178 · Cited by 159
The colony-stimulating factors and cancer
Metcalf, D. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2843 · Cited by 156
Behrens, F., Tak, P. P., Østergaard, M., Stoilov, R. M., Wiland, P., Huizinga, T. W. J., Berenfus, V. Y., Vladeva, S., Rech, J., Rubbert‐Roth, A., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204816 · Cited by 152
Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications
Rutella, S., & Lemoli, R. M. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.04.015 · Cited by 147
Granulocyte–macrophage colony-stimulating factor: not just another haematopoietic growth factor
Francisco‐Cruz, A., Aguilar‐Santelises, M., Ramos‐Espinosa, O., Mata‐Espinosa, D., Marquina‐Castillo, B., Barrios‐Payán, J., & Hernández‐Pando, R. (2013) · Medical Oncology · doi:10.1007/s12032-013-0774-6 · Cited by 146
Τακακι, S., Kanazawa, H., Shiiba, M., & Takatsu, K. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.11.7404-7413.1994 · Cited by 144
Anastasi, E., Campese, A. F., Bellavia, D., Bulotta, A., Balestri, A., Pascucci, M., Checquolo, S., Gradini, R., Lendahl, U., Frati, L., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.9.4504 · Cited by 143
Gangi, E., Vasu, C., Cheatem, D., & Prabhakar, B. S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.7006 · Cited by 143
Self-citationMetcalf, D. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.9.5327 · Cited by 138
Three-dimensional structure of recombinant human granulocyte-macrophage colony-stimulating factor
Walter, M. R., Cook, W. J., Ealick, S. E., Nagabhushan, T. L., Trotta, P. P., & Bugg, C. E. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90470-5 · Cited by 138
Lopez, A. F., Eglinton, J. M., Gillis, D., et al. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.18.7022 · Cited by 130
Rutella, S., Bonanno, G., Pierelli, L., Mariotti, A., Capoluongo, E., Contemi, A. M., Ameglio, F., Curti, A., Ritis, D. G. D., Voso, M. T., et al. (2004) · European Journal of Immunology · doi:10.1002/eji.200324651 · Cited by 130
Mueller, M. M., Herold‐Mende, C. C., Riede, D., Lange, M., Steiner, H. H., & Fusenig, N. E. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65472-7 · Cited by 129
Burmester, G. R., Feist, E., Sleeman, M., Wang, B., White, B., & Magrini, F. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.146225 · Cited by 127
GM-CSF–Responsive Monocyte-Derived Dendritic Cells Are Pivotal in Th17 Pathogenesis
Ko, H., Brady, J. L., Ryg-Cornejo, V., Hansen, D. S., Vremec, D., Shortman, K., Zhan, Y., & Lew, A. M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302040 · Cited by 119
Cebon, J. S., Nicola, N. A., Ward, M. A., et al. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39589-4 · Cited by 116
The Colony-Stimulating Factors and Cancer
Metcalf, D. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0151 · Cited by 113
Bischof, R. J., Zafiropoulos, D., Hamilton, J. A., & Campbell, I. K. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01125.x · Cited by 112
Tsuchiya, Y., Igarashi, M., Suzuki, R., & Kumagai, K. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.2.699 · Cited by 110
Granulocyte-macrophage colony stimulating factor exacerbates collagen induced arthritis in mice
Campbell, I. K., Bendele, A. M., Smith, D. A., & Hamilton, J. A. (1997) · Annals of the Rheumatic Diseases · doi:10.1136/ard.56.6.364 · Cited by 110
Antitumor effects of granulocyte-macrophage colony-stimulating factor production by melanoma cells.
Armstrong, C. A., Botella, R., Galloway, T. H., Murray, N., Kramp, J.-P., Song, I. S., & Ansel, J. C. (1996) · PubMed · Cited by 109
Park, L. S., Martin, U., Sorensen, R., Luhr, S., Morrissey, P., Cosman, D. J., & Larsen, A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4295 · Cited by 109
Signalling by the βc family of cytokines
Hercus, T. R., Dhagat, U., Kan, W. L., Broughton, S. E., Nero, T. L., Perugini, M., Sandow, J. J., D’Andrea, R. J., Ekert, P. G., Hughes, T. P., et al. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.03.002 · Cited by 106
Vasu, C., Dogan, R.-N. E., Holterman, M., & Prabhakar, B. S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.11.5511 · Cited by 104
Self-citationSakagami, T., Beck, D. C., Uchida, K., Suzuki, T., Carey, B. C., Nakata, K., Keller, G. L., Wood, R. E., Wert, S. E., Ikegami, M., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201001-0008oc · Cited by 103
Bhattacharya, P., Gopisetty, A., Ganesh, B. B., et al. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0310154 · Cited by 103
Self-citationIdiotype vaccines for lymphoma: proof-of-principles and clinical trial failures
Bendandi, M. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2717 · Cited by 100
Ganesh, B. B., Cheatem, D., Sheng, J. R., Vasu, C., & Prabhakar, B. S. (2009) · International Immunology · doi:10.1093/intimm/dxn147 · Cited by 95
Self-citationTakaki, S., Kanazawa, H., Shiiba, M., et al. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.11.7404 · Cited by 95
GM-CSF as a therapeutic target in inflammatory diseases
van Nieuwenhuijze, A. E. M., Koenders, M. I., Roeleveld, D. M., Sleeman, M. A., van den Berg, W., & Wicks, I. P. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.05.002 · Cited by 93
Faries, M. B., Hsueh, E. C., Ye, X., Hoban, M., & Morton, D. L. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1540 · Cited by 91
Growth factor pleiotropy is controlled by a receptor Tyr/Ser motif that acts as a binary switch
Guthridge, M. A., Powell, J. A., Barry, E. F., Stomski, F. C., McClure, B. J., Ramshaw, H. S., Felquer, F. A., Dottore, M., Thomas, D., To, B., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600948 · Cited by 89
Redman, B. G., Chang, A. E., Whitfield, J. R., Esper, P., Jiang, G., Braun, T., Roessler, B. J., & Mulé, J. J. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31817fd90b · Cited by 87
Functional defect in regulatory T cells in myasthenia gravis
Thiruppathi, M., Rowin, J., Jiang, Q. L., Sheng, J. R., Prabhakar, B. S., & Meriggioli, M. N. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06840.x · Cited by 87
Self-citationKorn, T., Anderson, A. C., Bettelli, E., & Oukka, M. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.09.009 · Cited by 85
Li, G., Kim, Y., & Broxmeyer, H. E. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4706 · Cited by 85
Macrophage lineage phenotypes and osteoclastogenesis—Complexity in the control by GM-CSF and TGF-β
Lari, R., Fleetwood, A. J., Kitchener, P. D., Cook, A. D., Pavasovic, D., Hertzog, P. J., & Hamilton, J. A. (2006) · Bone · doi:10.1016/j.bone.2006.09.003 · Cited by 85
Guthridge, M. A., Barry, E. F., Felquer, F. A., McClure, B. J., Stomski, F. C., Ramshaw, H. S., & Lopez, A. F. (2003) · Blood · doi:10.1182/blood-2003-06-1999 · Cited by 79
Lin, M., Isa, S. A. B. M., Wang, S., Cher, B. P., Nih, F. W., Kotaka, M., & Ruedl, C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903873 · Cited by 78
Cheatem, D., Ganesh, B. B., Gangi, E., Vasu, C., & Prabhakar, B. S. (2009) · Clinical Immunology · doi:10.1016/j.clim.2008.12.001 · Cited by 78
Self-citationGMCSF activates NF-κB via direct interaction of the GMCSF receptor with IκB kinase β
Ebner, K., Bandion, A., Binder, B. R., de Martin, R., & Schmid, J. A. (2003) · Blood · doi:10.1182/blood-2002-12-3753 · Cited by 78
Sheng, J. R., Li, L., Ganesh, B. B., Vasu, C., Prabhakar, B. S., & Meriggioli, M. N. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.8.5296 · Cited by 77
Self-citationBenwell, R. K., & Lee, D. R. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.09.013 · Cited by 70
Gopisetty, A., Bhattacharya, P., Haddad, C., Bruno, J. C., Vasu, C., Miele, L., & Prabhakar, B. S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202298 · Cited by 69
Self-citationMiller, G., Pillarisetty, V. G., Shah, A. B., Lahrs, S., Xing, Z., & DeMatteo, R. P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.2875 · Cited by 69
Mayer, C. T., Berod, L., & Sparwasser, T. D. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00183 · Cited by 68
Perugini, M., Brown, A. L., Salerno, D. G., Booker, G. W., Stojkoski, C., Hercus, T. R., Lopez, A. F., Hibbs, M. L., Gonda, T. J., & D’Andrea, R. J. (2010) · Blood · doi:10.1182/blood-2009-08-235846 · Cited by 66
Rowin, J., Thiruppathi, M., Arhebamen, E., Sheng, J., Prabhakar, B. S., & Meriggioli, M. N. (2012) · Muscle & Nerve · doi:10.1002/mus.23488 · Cited by 64
Self-citationComalada, M., Xaus, J., Sànchez‐Tilló, E., Valledor, A. F., & Celada, A. (2004) · European Journal of Immunology · doi:10.1002/eji.200425110 · Cited by 59
Kriegel, M. A., Rathinam, C., & Flavell, R. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115308109 · Cited by 59
Chang, G., Lan, H.-C. H., Juang, S., Wu, Y., Lee, H., Hung, Y., Yang, H., Whang‐Peng, J., & Liu, K. (2005) · Cancer · doi:10.1002/cncr.20843 · Cited by 58
Characterisation of the expression and function of the GM‐CSF receptor α‐chain in mice
Rosas, M., Gordon, S., & Taylor, P. R. (2007) · European Journal of Immunology · doi:10.1002/eji.200636892 · Cited by 57
The inflammatory cytokine, GM ‐ CSF , alters the developmental outcome of murine dendritic cells
Zhan, Y., Vega‐Ramos, J., Carrington, E. M., Villadangos, J. A., Lew, A. M., & Xu, Y. (2012) · European Journal of Immunology · doi:10.1002/eji.201242477 · Cited by 56
Role of colony-stimulating factors in atherosclerosis
Di Gregoli, K., & Johnson, J. L. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328357ca6e · Cited by 55
Sebastián, C., Serra, M., Yeramian, A., Serrat, N., Lloberas, J., & Celada, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.5898 · Cited by 54
Sheng, J. R., Thiruppathi, M., Prabhakar, B. S., & Meriggioli, M. N. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.10.010 · Cited by 52
Self-citationDäbritz, J., Bonkowski, E. L., Chalk, C., Trapnell, B. C., Langhorst, J., Denson, L. A., & Foell, D. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.360 · Cited by 51
Roth, L., MacDonald, J. K., McDonald, J. W., & Chande, N. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22973 · Cited by 46
Marlow, N., Morris, T. P., Brocklehurst, P., Carr, R. A., Cowan, F. M., Patel, N. V., Petrou, S., Redshaw, M., Modi, N., & Doré, C. J. (2012) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/fetalneonatal-2011-301470 · Cited by 42
IL-1β Promotes TGF-β1 and IL-2 Dependent Foxp3 Expression in Regulatory T Cells
Ganesh, B. B., Bhattacharya, P., Gopisetty, A., Sheng, J., Vasu, C., & Prabhakar, B. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021949 · Cited by 32
Self-citationMausberg, A. K., Jander, S., & Reichmann, G. (2009) · Glia · doi:10.1002/glia.20853 · Cited by 32
Muls, N., Jnaoui, K., Dang, H. A., Wauters, A., Snick, J. V., Sindic, C., & Pesch, V. V. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.12.010 · Cited by 31
Strategies for Treating Autoimmunity: Novel Insights from Experimental Myasthenia Gravis
Meriggioli, M. N., Sheng, J. R., Li, L., & Prabhakar, B. S. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1405.023 · Cited by 29
Self-citationEggermont, A. M. M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2377 · Cited by 29
Sargramostim (GM-CSF) for induction of remission in Crohn's disease
Roth, L., MacDonald, J. K., McDonald, J. W., & Chande, N. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008538.pub2 · Cited by 20
Domínguez, P. M., López‐Bravo, M., Kalinke, U., & Ardavı́n, C. (2011) · European Journal of Immunology · doi:10.1002/eji.201141674 · Cited by 15
Phase II clinical trial evaluating docetaxel, vinorelbine and GM-CSF in stage IV melanoma
Eroglu, Z., Kong, K. M., Jakowatz, J. G., Samlowski, W. E., & Fruehauf, J. P. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1703-z · Cited by 11
Epstein-Barr virus-dependent lymphoproliferative disease: critical role of IL-6
(2000) · Pure Amsterdam UMC · doi:10.1002/1521-4141(200007)30:7 · Cited by 1
Cited by
Integrating oncolytic viruses in combination cancer immunotherapy
Bommareddy, P. K., Shettigar, M., & Kaufman, H. L. (2018) · Nature reviews. Immunology · doi:10.1038/s41577-018-0014-6 · Cited by 704
Pharmaco-Immunomodulatory Therapy in COVID-19
Rizk, J. G., Kalantar-Zadeh, K., Mehra, M. R., Lavie, C. J., Rizk, Y., & Forthal, D. N. (2020) · Drugs · doi:10.1007/s40265-020-01367-z · Cited by 288
GM-CSF: A Double-Edged Sword in Cancer Immunotherapy
Kumar, A., Taghi Khani, A., Sanchez Ortiz, A., & Swaminathan, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.901277 · Cited by 265
Dynamic lipidome alterations associated with human health, disease and ageing
Hornburg, D., Wu, S., Moqri, M., Zhou, X., Contrepois, K., Bararpour, N., Traber, G. M., Su, B., Metwally, A. A., Avina, M., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00880-1 · Cited by 260
Kim, W., Lee, E. J., Bae, I., Myoung, K., Kim, S. T., Park, P. J., Lee, K., Pham, A. V. Q., Ko, J., Oh, S. H., et al. (2020) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2020.1793514 · Cited by 232
Metadata
- Authors
- Bhattacharya, P., Budnick, I., Singh, M., Thiruppathi, M., Alharshawi, K., Elshabrawy, H., Holterman, M. J., & Prabhakar, B. S.
- Venue
- Journal of Interferon & Cytokine Research
- Publisher
- SAGE Publications
- Published
- 2015-08
- Volume
- 35
- Issue
- 8
- Pages
- 585-599
- ISSN
- 1079-9907 (ISSN-L)
- 1557-7465
- OpenAlex
- W2322706669
- Cited by
- 264
- References
- 160
- FWCI
- 8.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.